PHARMO, a Lumanity business, is a Gold conference sponsor and exhibitor at the International Society for Pharmacoepidemiology 2024 annual meeting in Berlin. Visit us at booth 901 and check out our thirteen presentations, including four oral presentations and twelve posters.
Oral Presentations:
- Target Trial Emulation with Real World Evidence: Regulatory Grade Pharmacoepidemiology in the SIGMA consortium
- GP consultation for menstrual disorders after COVID-19 vaccination – a self-controlled cohort study based on healthcare data from the Netherlands
- Impact of data source diversity on the distribution of key variables in cohorts of pregnancies extracted with the ConcePTION algorithm leveraging on a random forest imputation model
- Unravelling Sex Disparities in Statin Dose Titration Patterns in Primary Care
Posters:
- Interim results from the VAC4EU Post-Authorization Safety Study (PASS) among recipients of the Pfizer-BioNTech COVID-19 (Comirnaty®) vaccine in Europe
- Safety of the Janssen COVID-19 vaccine (JCOVDEN) using VAC4EU European Healthcare Data: Methods and Results of the Second Study Feasibility Assessment
- Migration background and HbA1c Checks and Balances: a large routine care data study in the Netherlands
- Readiness of electronic healthcare record data sources for rapid evaluation of safety signals of SARS-CoV-2 Vaccines in Europe: results from the Covid-19 Vaccine Monitoring project
- Challenges of multi-country post-authorisation safety studies for surveillance of new medical products
- Oral antihypertensives in hypertensive pregnancy and the association with fetal growth: a population-based cohort study
- Characteristics of Patients with ATTR Amyloidosis and Methodological Approaches for Establishing Clinical Subtype in the Netherlands
- Rates of SARS-CoV-2 breakthrough infection or severe COVID-19 and associated risk factors after primary and booster vaccination against COVID-19 in the Netherlands
- Identifying and profiling patients with heart failure in a population-based cohort through linkage of primary and secondary care data
- Factor XA Inhibitor-related major bleeding events in the Netherlands
- Use of SGLT2 Inhibitors in Patients With Type 2 Diabetes and Chronic Kidney Disease – a Multi-Country Report from the FOUNTAIN Platform
- Exploring sources of statistical heterogeneity in a multi-database observational study: results from a case study using EXACOS-CV
This conference brings together more than 1,400 leaders representing industry, service providers, government/regulatory agencies, academia, consultants and student from many countries – all dedicated to advancing the health of the public.
Schedule time to meet with our attending staff by reaching out to contact@lumanity.com